Caricamento...
CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
Human cancers harbor substantial genetic, epigenetic, and transcriptional changes, only some of which drive oncogenesis at certain times during cancer evolution. Identifying the cancer-driver alterations amongst the vast swathes of “passenger” changes still remains a major challenge. Transposon and...
Salvato in:
| Pubblicato in: | Genome Biol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7437018/ https://ncbi.nlm.nih.gov/pubmed/32811551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13059-020-02118-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|